Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Patent Number 11884722

US 11884722 B2
Application Number18157800
Publication NumberUS 20230227548 A1
Pendency1 year, 10 days
Filled DateJan 20, 2023
Priority DateJul 20, 2016
Publication DateJul 20, 2023
Expiration DateJul 19, 2036
Inventor/ApplicantsYingzhe Li
Nathan Majewski
Mark Tornetta
Suzanne Edavettal
Mark Mendonca
Kodandaram Pillarisetti
Alexey Teplyakov
Leopoldo L. Luistro, III
Francois Gaudet
Ricardo Attar
Diana Chin
Leopoido Luistro
ExaminesNATARAJAN, MEERA
Art Unit1643
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.